HUP0102388A3 - Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease - Google Patents

Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease

Info

Publication number
HUP0102388A3
HUP0102388A3 HU0102388A HUP0102388A HUP0102388A3 HU P0102388 A3 HUP0102388 A3 HU P0102388A3 HU 0102388 A HU0102388 A HU 0102388A HU P0102388 A HUP0102388 A HU P0102388A HU P0102388 A3 HUP0102388 A3 HU P0102388A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical composition
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
HU0102388A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HU0102388D0 publication Critical patent/HU0102388D0/hu
Publication of HUP0102388A2 publication Critical patent/HUP0102388A2/hu
Publication of HUP0102388A3 publication Critical patent/HUP0102388A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0102388A 2000-06-09 2001-06-08 Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease HUP0102388A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00401646A EP1161949A1 (en) 2000-06-09 2000-06-09 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease

Publications (3)

Publication Number Publication Date
HU0102388D0 HU0102388D0 (en) 2001-08-28
HUP0102388A2 HUP0102388A2 (hu) 2002-04-29
HUP0102388A3 true HUP0102388A3 (en) 2004-11-29

Family

ID=8173724

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102388A HUP0102388A3 (en) 2000-06-09 2001-06-08 Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease

Country Status (19)

Country Link
US (1) US6544983B2 (hu)
EP (1) EP1161949A1 (hu)
JP (1) JP2002138090A (hu)
KR (1) KR20010111457A (hu)
CN (1) CN1345725A (hu)
AR (1) AR030291A1 (hu)
AU (1) AU5181301A (hu)
BR (1) BR0102289A (hu)
CA (1) CA2347337A1 (hu)
CZ (1) CZ20011999A3 (hu)
EA (1) EA200100515A3 (hu)
HU (1) HUP0102388A3 (hu)
IL (1) IL143636A0 (hu)
MX (1) MXPA01005726A (hu)
NO (1) NO20012831L (hu)
NZ (1) NZ512222A (hu)
PL (1) PL347922A1 (hu)
SK (1) SK7832001A3 (hu)
ZA (1) ZA200104616B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
ES2378374T3 (es) * 2003-11-20 2012-04-11 Astellas Pharma Inc. Inhibidores de la PDE 4 para el tratamiento de la cistitis intersticial
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
KR20090045233A (ko) 2006-07-10 2009-05-07 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
CA2711865A1 (en) 2008-01-11 2009-07-16 Astellas Pharma Inc. A pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN104968348B (zh) * 2012-05-22 2018-04-17 Paion英国有限公司 包含短效苯二氮杂*类化合物的组合物
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652352A1 (fr) 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv

Also Published As

Publication number Publication date
NO20012831D0 (no) 2001-06-08
EA200100515A3 (ru) 2002-06-27
CA2347337A1 (en) 2001-12-09
US6544983B2 (en) 2003-04-08
IL143636A0 (en) 2002-04-21
CN1345725A (zh) 2002-04-24
PL347922A1 (en) 2001-12-17
EA200100515A2 (ru) 2001-12-24
BR0102289A (pt) 2002-03-12
CZ20011999A3 (cs) 2002-04-17
AU5181301A (en) 2001-12-13
KR20010111457A (ko) 2001-12-19
HUP0102388A2 (hu) 2002-04-29
ZA200104616B (en) 2002-10-30
NZ512222A (en) 2002-10-25
MXPA01005726A (es) 2003-08-20
HU0102388D0 (en) 2001-08-28
SK7832001A3 (en) 2002-05-09
AR030291A1 (es) 2003-08-20
US20020010175A1 (en) 2002-01-24
NO20012831L (no) 2001-12-10
JP2002138090A (ja) 2002-05-14
EP1161949A1 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
IL167900A (en) Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease
HUP0004211A3 (en) Use of pde-5 inhibitors for the preparation of pharmaceutical compositions treating pulmonary hypertension
ITMI20000312A0 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva
HUP0300059A3 (en) Quinazoline derivatives, process for their preparation, pharmaceutical compositions containing the compounds and use of the new and known quinazoline derivatives against proliferative disease
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0102039A3 (en) Use of paclitaxel stabilized with albumin for the preparation of pharmaceutical compositions treating solid tumors and the pharmaceutical compositions obtained thereby
AU2291001A (en) Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
HUP0400041A2 (hu) Epotilonszármazékok alkalmazása makacs tumorok kezelésére szolgáló gyógyszerkészítmények előállítására
HUP0104085A3 (en) Use of vasopressin antagonists for the preparation of pharmaceutical compositions treating pulmonary hypertension
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0301075A3 (en) Diphenyl ether derivatives, their use for preparation of pharmaceutical compositions and process for preparation the compounds
HUP0102388A3 (en) Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
EE05543B1 (et) Tuumorinekroositeguri antagonisti kasutamine endometrioosi raviks ette n„htud farmatseutilise kompositsiooni valmistamiseks
IL161348A (en) Substituted 4- phenyl-4-[1h - imidazol-2-yl] piperidine derivatives and their use for the preparation of pharmaceutical compositions
WO2002017894A3 (en) Pharmaceutical formulation of salmeterol and fluticasone propionate
HUP0301317A3 (en) Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
HUP0204391A3 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
HUP0401633A3 (en) Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension
HUP0302291A3 (en) Sulfonamide derivatives, process for their preparation and their use for preparation of pharmaceutical compositions
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
HK1038703A1 (zh) 糖皮質類固醇在制備治療輕度/早期copd(慢性阻塞性肺病)的藥物中的應用
AU4335901A (en) Novel therapeutic treatment of chronic obstructive pulmonary disease
IL150403A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF